In vivo activation of LAK cells during systemic IL-2 therapy
Lang, P.; Vitté-Mony, I.; Farace, F.; Stancou, R.; Triebel, F.; Escudier, B.; Hercend, T.; Bertoglio, J.
European Cytokine Network 1(3): 185-188
1990
ISSN/ISBN: 1148-5493 PMID: 2129800 Document Number: 360120
Document emailed within 1 workday
Related Documents
Essani, N.A.; McGuire, G.M.; Manning, A.M.; Jaeschke, H. 1996: Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo Journal of Immunology 156(8): 2956-2963Liu, S.F.; Ye, X.; Malik, A.B. 1997: In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock Journal of Immunology 159(8): 3976-3983
Tuttle, T.M.; Inge, T.H.; Bethke, K.P.; McCrady, C.W.; Pettit, G.R.; Bear, H.D. 1992: Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1 Cancer Research 52(3): 548-553
Zhou, J.-j.; Wang, G.-s.; Li, X.-p.; Li, X.-m.; Qian, L. 2013: Activation of hypomethylated DNA on plasmacytoid dendritic cells in patients with systemic lupus erythematosus Zhonghua Yi Xue Za Zhi 93(39): 3119-3121
Stanislav, M.L.; Balabanova, R.M.; Nikonova, M.F.; Litvina, M.M.; Iarilin, A.A. 2000: Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus Terapevticheskii Arkhiv 72(5): 44-49
Lovgren, T.R.; Tarantolo, S.R.; Evans, C.; Kuszynski, C.A.; Joshi, S.S. 2002: Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors In Vivo 16(6): 541-550
Bukvić-Knor, T. 1989: The effect of steroid therapy on cellular reactions in vivo in patients with cutaneous and systemic forms of erythematosus Medicinski Arhiv 43(2-3): 137-140
Schmidt, K.G.; Rasmussen, J.W. 1984: Acute platelet activation induced by smoking. in vivo and ex vivo studies in humans Thrombosis and Haemostasis 51(2): 279-282
Tanaka, Y.; Saito, K.; Suzuki, H.; Eto, S.; Yamashita, U. 1989: Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression Journal of Immunology 143(5): 1584-1590
Phillips, D.H.; Hewer, A.; Grover, P.L. 1985: Aberrant activation of benzo(a)pyrene in cultured rat mammary cells in vitro and following direct application to rat mammary glands in vivo Cancer Research 45(9): 4167-4174
Fidler, I.J.; Fan, D.; Ichinose, Y. 1989: Potent in situ activation of murine lung macrophages and therapy of melanoma metastases by systemic administration of liposomes containing muramyltripeptide phosphatidylethanolamine and interferon gamma Invasion and Metastasis 9(2): 75-88
Wu, S.; Guo, N.; Hou, Y. 1996: Effects of systemic fluconazole therapy on in vitro adhesion of Candida albicans to buccal epithelial cells and changes of the cell surface proteins of the epithelial cells Chinese Medical Sciences Journal 11(1): 45-48
Demeter, J.; Paloczi, K.; Bibok, G.; Lehoczky, D. 1992: Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy Leukemia 6(Suppl 3): 41s-45s
Noonan, F.P.; Bucana, C.; Sauder, D.N.; De Fabo, E.C. 1984: Mechanism of systemic immune suppression by UV irradiation in vivo. II. the UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies Journal of Immunology 132(5): 2408-2416
Pederson, L.C.; Buchsbaum, D.J.; Vickers, S.M.; Kancharla, S.R.; Mayo, M.S.; Curiel, D.T.; Stackhouse, M.A. 1997: Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo Cancer Research 57(19): 4325-4332
Palmetshofer, A.; Galili, U.; Dalmasso, A.P.; Robson, S.C.; Bach, F.H. 1998: Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation Transplantation 65(6): 844-853
Hahn, A.B.; Soloski, M.J. 1989: Anti-Qa-2-induced T cell activation. the parameters of activation, the definition of mitogenic and nonmitogenic antibodies, and the differential effects on CD4+ vs CD8+ T cells Journal of Immunology 143(2): 407-413
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Tsutsui, M.; Yanagihara, N.; Miyamoto, E.; Kuroiwa, A.; Izumi, F. 1994: Correlation of activation of Ca2+/calmodulin-dependent protein kinase Ii with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells Molecular Pharmacology 46(6): 1041-1047
Tan, T.-W.; Lin, Y.-T.; Yang, J.-S.; Lu, C.-C.; Chiang, J.-H.; Wu, C.-L.; Lin, J.-P.; Tang, N.-Y.; Yeh, C.-C.; Fan, M.-J.; Chung, J.-G. 2009: A. cantoniensis inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immunoresponses in vivo In Vivo 23(4): 561-566